15-Deoxy-delta(12,14)-prostaglandin J(2) down-regulates CXCR4 on carcinoma cells through PPARgamma- and NFkappaB-mediated pathways. (Q40091899)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707368%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

title

15-Deoxy-delta(12,14)-prostaglandin J(2) down-regulates CXCR4 on carcinoma cells through PPARgamma- and NFkappaB-mediated pathways (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707368%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707368%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Cynthia Lee Richard

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707368%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Erica Lauren Lowthers

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707368%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

language of work or name

English

0 references

publication date

13 July 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707368%20AND%20SRC:MED&resulttype=core&format=json

Experimental Cell Research

3 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707368%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

volume

313

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707368%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

issue

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707368%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

page(s)

3446-3458

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707368%20AND%20SRC:MED&resulttype=core&format=json

Microenvironmental and cellular consequences of altered blood flow in tumours

3 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Tumor microenvironmental physiology and its implications for radiation oncology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Prostaglandins and leukotrienes: advances in eicosanoid biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

COX-2: a target for colon cancer prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

COX-2: a molecular target for colorectal cancer prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

The role of prostaglandins and other eicosanoids in the gastrointestinal tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Differential expression of cyclooxygenase 2 in human colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Accelerated recovery of 5-fluorouracil-damaged bone marrow after rosiglitazone treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Cyclooxygenase-2 expression: a significant prognostic indicator for patients with colorectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Patients with adenomatous polyps and carcinomas have increased colonic mucosal prostaglandin E2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Prostaglandin levels in human colorectal mucosa: effects of sulindac in patients with familial adenomatous polyposis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Prostaglandin E2 enhances intestinal adenoma growth via activation of the Ras-mitogen-activated protein kinase cascade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Epidermal growth factor promotes the chemotactic migration of cultured rat intestinal epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Functional receptors for epidermal growth factor in an epithelial-cell line derived from the rat small intestine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Role of prostaglandin E2-dependent angiogenic switch in cyclooxygenase 2-induced breast cancer progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Cyclo-oxygenase-2 mediated prostaglandin release regulates blood flow in connective tissue during mechanical loading in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Role of nitric oxide and prostaglandin E2 in acute renal hypoperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Biosynthesis of lipoxygenase and cyclo-oxygenase products from [14C]-arachidonic acid by human colonic mucosa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Inhibitory effects of prostaglandin D2 against the proliferation of human colon cancer cell lines and hepatic metastasis from colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Characteristics of the peroxisome proliferator activated receptor gamma (PPARgamma) ligand induced apoptosis in colon cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated rece

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Chemokine receptor expression by human intestinal epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Inhibitory effects of anti-CXCR4 antibodies on human colon cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Adenosine upregulates CXCR4 and enhances the proliferative and migratory responses of human carcinoma cells to CXCL12/SDF-1alpha.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Adenosine down-regulates the surface expression of dipeptidyl peptidase IV on HT-29 human colorectal carcinoma cells: implications for cancer cell behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Adenosine downregulates DPPIV on HT-29 colon cancer cells by stimulating protein tyrosine phosphatase(s) and reducing ERK1/2 activity via a novel pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

cAMP-induced PKCzeta activation increases functional CXCR4 expression on human CD34+ hematopoietic progenitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

The role of PGE(2) in the differentiation of dendritic cells: how do dendritic cells influence T-cell polarization and chemokine receptor expression?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Prostaglandin E2 is generally required for human dendritic cell migration and exerts its effect via EP2 and EP4 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Alpha,beta-unsaturated ketone is a core moiety of natural ligands for covalent binding to peroxisome proliferator-activated receptor gamma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

15-deoxy-delta 12,14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

15-Deoxy-{delta}12,14-prostaglandin j2 inhibits interleukin-1{beta}-induced nuclear factor-{kappa}b in human amnion and myometrial cells: mechanisms and implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Gastrin promotes human colon cancer cell growth via CCK-2 receptor-mediated cyclooxygenase-2 induction and prostaglandin E2 production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Up-regulation of HIV coreceptor CXCR4 expression in human T lymphocytes is mediated in part by a cAMP-responsive element

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Effect of prostaglandin E(2) on the proliferation, Ca(2+) mobilization and cAMP in HT-29 human colon adenocarcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Demonstration of functional receptors for noradrenaline and adenosine-5'-triphosphate, but not for prostaglandin E2, in HT-29 human colon cancer cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Expression of prostaglandin D2 receptors DP1 and DP2 by human colorectal cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

delta 12-Prostaglandin J2, an ultimate metabolite of prostaglandin D2 exerting cell growth inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

15-deoxy-delta 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

PGD2 metabolism in plasma: Kinetics and relationship with bioactivity on DP1 and CRTH2 receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

An overview on biological mechanisms of PPARs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Differentiation and reversal of malignant changes in colon cancer through PPARgamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Peroxisome proliferator-activated receptors (PPARs) and associated transcription factors in colon cancer: reduced expression of PPARgamma-coactivator 1 (PGC-1).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Peroxisome proliferator-activated receptor expression and activation in normal human colonic epithelial cells and tubular adenomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

NF-kappaB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

15-Deoxy-Delta 12,14-prostaglandin J2 inhibition of NF-kappaB-DNA binding through covalent modification of the p50 subunit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

The Role of PPARγ on Restoration of Colonic Homeostasis After Experimental Stress-Induced Inflammation and Dysfunction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Regulation of the chemokine receptor CXCR4 by hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027

Stromal cell-derived factor-1alpha promotes melanoma cell invasion across basement membranes involving stimulation of membrane-type 1 matrix metalloproteinase and Rho GTPase activities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2007.06.027